O
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13D/A183.3 KBOrexigen Therapeutics, Inc.Jun 4, 4:52 PM ET·0001567619-19-012686
- 8-K248.2 KBOrexigen Therapeutics, Inc.May 23, 3:59 PM ET·0001193125-19-155290
- 8-K216.2 KBOrexigen Therapeutics, Inc.May 2, 9:27 PM ET·0001193125-19-135487
- 8-K214.8 KBOrexigen Therapeutics, Inc.Apr 2, 4:38 PM ET·0001193125-19-095688
- 8-K215.6 KBOrexigen Therapeutics, Inc.Mar 4, 4:01 PM ET·0001193125-19-062410
- SC 13G/A225.6 KBOrexigen Therapeutics, Inc.Feb 14, 5:20 PM ET·0000921895-19-000488
- SC 13G/A27.2 KBOrexigen Therapeutics, Inc.Feb 14, 3:51 PM ET·0001537055-19-000004
- SC 13G/A63.4 KBOrexigen Therapeutics, Inc.Feb 12, 3:36 PM ET·0001213900-19-002219
- SC 13G/A50.5 KBOrexigen Therapeutics, Inc.Feb 12, 3:05 PM ET·0001213900-19-002211
- SC 13G/A129.5 KBOrexigen Therapeutics, Inc.Feb 11, 2:29 PM ET·0000905148-19-000275
Insiders
10- ACE HEATHER SEVP, Global Human Resources
- Arkin Moshemember of 10% owner group
- BAUM CAROL AVP, Commercialization
- Baupost Group GP, L.L.C.10% Owner
- BAUPOST GROUP LLC/MA10% Owner
- BLAIR JAMES C10% Owner
- BOCK LOUIS CDirector
- Booth Mark DChief Commercial Officer
- Cannell Thomas RChief Commercial Officer
- COOPER GRAHAM KCFO and Treasurer
Tickers
No tickers on record
Addresses
business
3344 N. TORREY PINES CT. SUITE 200
LA JOLLA, CA, 92037
mailing
3344 N. TORREY PINES CT. SUITE 200
LA JOLLA, CA, 92037